葵花药业：复方聚乙二醇电解质口服溶液获药品注册证

Group 1 - The company, Kewang Pharmaceutical (002737), announced that its subsidiary has received the drug registration certificate from the National Medical Products Administration for the compound polyethylene glycol (3350) electrolyte oral solution [1] - The approved indications for the drug include the treatment of chronic constipation and fecal impaction [1]